World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02290860
Date of registration: 10/11/2014
Prospective Registration: Yes
Primary sponsor: Université de Sherbrooke
Public title: Screening Type 2 Diabetes Mellitus on the 2nd Day After Delivery in Women With Gestational Diabetes Mellitus SoL
Scientific title: Screening Type 2 Diabetes Mellitus on the 2nd Day After Delivery in Women With Gestational Diabetes Mellitus - Stage 2, a Multicentre Trial.
Date of first enrolment: December 2014
Target sample size: 228
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02290860
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Canada
Contacts
Name:     Jean-Luc Ardilouze, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Key inclusion & exclusion criteria

Inclusion Criteria:

- Women aged between 18 and 45 years;

- Having a positive diagnosis of gestational diabetes mellitus (GDM) (IADPSG or CDA
criteria or patient followed for GDM);

- Treated with diet, insulin or oral hypoglycemic agents;

- Have given birth to a child at term (gestational age = 37 weeks);

- Have signed the consent form.

Exclusion Criteria:

- History of glucose intolerance or diabetes before the pregnancy;

- Have presented another obstetrical pathology during the pregnancy;

- Severe gestational high blood pressure with proteinuria;

- Delayed intrauterine development syndrome;

- Pregnancy with more than a foetus;

- Drug addiction;

- Had complications during the delivery such as:

- Moderate to severe postpartum bleeding;

- Surgery in postpartum (curettage, hysterectomy, etc.).



Age minimum: 18 Years
Age maximum: 45 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Diabetes, Gestational
Intervention(s)
Procedure: Type 2 diabetes diagnosis test
Primary Outcome(s)
abnormal glucose tolerance [Time Frame: 8 weeks after delivery]
Secondary Outcome(s)
Secondary ID(s)
14-161
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of Toronto
University of Manitoba
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history